AUPH
Aurinia Pharmaceuticals Inc
8.80
USD
This page is just a preview of the data found in TrendSpider’s full version
Aurinia Pharmaceuticals Inc stock is up 6.15% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 10 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 30 Nov 14:35 | 19 Jan, 2024 | 9.00 | 2237 | ||
| 30 Nov 16:31 | 19 Apr, 2024 | 10.00 | 2343 | ||
| 01 Dec 20:52 | 19 Apr, 2024 | 10.00 | 2124 | ||
| 01 Dec 20:59 | 19 Jan, 2024 | 9.00 | 2294 | ||
| 04 Dec 18:20 | 19 Jan, 2024 | 9.00 | 2370 | ||
| 04 Dec 18:52 | 19 Jan, 2024 | 9.00 | 2370 | ||
| 05 Dec 17:53 | 19 Jan, 2024 | 7.00 | 1754 | ||
| 05 Dec 19:54 | 19 Jan, 2024 | 8.00 | 5377 | ||
| 05 Dec 20:39 | 19 Jan, 2024 | 7.00 | 1754 | ||
| 05 Dec 20:53 | 19 Apr, 2024 | 10.00 | 2449 |
Aurinia Pharmaceuticals Inc. focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis.
